GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

HeraMED HMD.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.04

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2024

Revenue

A$364,300

FY2016FY2024

Net income

−A$5.5m

FY2016FY2024

Free cash flow

−A$4.8m

FY2016FY2024

Shareholders' equity

A$2.8m

FY2016FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueA$364,300A$606,200A$334,000A$129,200A$39,500A$145,400A$77,200——
Gross profitA$218,600A$364,000A$214,600A$66,200A$7,900A$33,800−A$56,900——
Research and developmentA$1.3mA$2.1mA$1.2mA$2.3mA$1.2mA$922,700A$473,100A$241,000A$1.6m
Operating income−A$5.5m−A$6.7m−A$4.9m−A$5.9m−A$3.4m−A$3.2m−A$2.8m−A$643,000−A$2.0m
Net income−A$5.5m−A$6.8m−A$7.4m−A$8.5m−A$3.4m−A$3.1m−A$3.8m−A$788,000−A$2.1m
Diluted earnings per share-0.01-0.03-0.03-0.05-0.03-0.04-0.10-0.02-0.05

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsA$4.5mA$3.0mA$6.7mA$6.8mA$3.2mA$3.6mA$5.5mA$1.3mA$1.7m
Cash and short-term investmentsA$3.1mA$1.1mA$4.0mA$5.3mA$1.9mA$2.0mA$4.0mA$46,000A$1.4m
Total liabilitiesA$1.7mA$2.3mA$2.3mA$7.0mA$1.2mA$1.2mA$1.2mA$1.1mA$860,000
DebtA$157,000A$306,700A$271,800A$5.1mA$191,600A$241,100A$157,200A$303,000A$216,000
Shareholders' equityA$2.8mA$686,000A$4.4m−A$158,000A$2.0mA$2.4mA$4.3mA$205,000A$877,000
Shares outstanding532m269m221m181m130m89m37m41m41m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−A$4.8m−A$5.7m−A$3.9m−A$4.8m−A$2.8m−A$2.6m−A$1.8m−A$547,000−A$1.4m
Capital spending—−A$2,100−A$1.1m−A$127,300−A$67,300−A$207,200−A$177,900−A$841,000−A$307,000
Free cash flow−A$4.8m−A$5.7m−A$5.0m−A$4.9m−A$2.8m−A$2.9m−A$1.9m−A$1.4m−A$1.7m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueA$139,500A$183,400A$180,900A$308,500A$297,800A$78,900A$140,000A$65,400
Gross profitA$63,600A$126,000A$92,600A$127,400A$236,700A$59,800A$80,800A$31,300
Operating income−A$1.7m−A$2.3m−A$3.2m−A$3.4m−A$3.3m−A$1.5m−A$1.7m−A$2.2m
Net income−A$2.3m−A$2.3m−A$3.2m−A$3.5m−A$3.2m−A$1.7m−A$3.2m−A$4.0m
Diluted earnings per share-0.00-0.00-0.01-0.01-0.01-0.01-0.02-0.02
Total assetsA$1.6mA$4.5mA$3.1mA$3.0mA$3.6mA$4.4mA$3.2mA$4.6m
Cash and short-term investmentsA$954,500A$3.1mA$1.4mA$1.1mA$1.2mA$2.6mA$1.9mA$3.6m
Debt—A$82,100A$192,600A$260,600A$256,200A$178,200A$176,000A$3.4m
Shareholders' equityA$576,000A$2.8mA$1.2mA$686,000A$1.1mA$2.9mA$2.0m−A$106,000

Growth per year

Compound annual rate

3 years5 years10 years
Revenue41.3%20.2%—
Operating income-2.4%11.5%—
Net income-13.6%11.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin60.0%60.2%55.9%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-1.2-0.6-2.3-3.1-2.6-2.8-1.0
Price to sales18.46.651.2207.3223.860.247.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.